Life Science & Medical Technology

Japan advances iPSC-based transplantations in heart disease treatments

Japan is advancing research to apply induced pluripotent stem cell (iPSC) to treat heart diseases. After the world’s first-of-its-kind iPSC-based heart cell transplant in January, a second clinical trial has been approved this summer and the third is in the pipeline. Currently, cardiac insufficiency can only be cured by transplants but the waiting list for a donor is long. There are hopes that the new treatment will provide new alternatives in the future.